Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1705 - 1712 of 11621 results
Watching The DTSA Court Split On Inevitable Disclosure
October 18, 2022| News
California Privacy Rights Act: Key Compliance Tasks for Employers
October 17, 2022| Alert| Viewpoint
Pay Range(r)s: A (Pocket) Field Guide to Pay Transparency
October 17, 2022| Blog| Viewpoint
ESG Considerations in M&A Transactions
October 14, 2022| Advisory| Viewpoint
Pharma Refines Tricks To Tackle Section 112 But Left Frustrated
October 14, 2022| News
Energy & Sustainability Connections — October 2022
October 13, 2022| Article| Viewpoint
Energy & Sustainability Legal Feature — Recently Announced Clean Hydrogen Hub Program Funding
October 13, 2022| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.